Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 08553/0749.
Ranolazine Dr. Reddy's 375 mg, 500 mg, 750 mg Prolonged-release tablets
Ranolazine Dr. Reddy’s 375 mg, 500 mg, 750 mg Prolonged-release tablets
ranolazine
1. What Ranolazine is and what it is used for
2. What you need to know before you take Ranolazine
3. How to take Ranolazine
4. Possible side effects
5. How to store Ranolazine
6. Contents of the pack and other information
Ranolazine is a medicine used in combination with other medicines to treat angina pectoris, which is a chest pain or discomfort that you feel anywhere along the upper part of your body between your neck and upper abdomen, often brought on by exercise or too much activity.
You must talk to a doctor if you do not feel better or if you feel worse.
Talk to your doctor before taking Ranolazine
Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.
Do not use the following medicines if you take Ranolazine
Tell your doctor or pharmacist before you take Ranolazine if you use:
Tell your doctor or pharmacist if you are taking have recently taken or might take any other medicines.
Ranolazine can be taken with or without food. While being treated with this medicine, you should not drink grapefruit juice.
You should not take this medicine if you are pregnant unless your doctor has advised you to do so.
You should not take this medicine if you are breastfeeding. Ask your doctor for advice if you are breastfeeding.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
No studies on the effects of this medicine on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.
Ranolazine may cause side effects such as dizziness (common), blurred vision (uncommon), confusional state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems (rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.
Ranolazine 750 mg prolonged-release tablets contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
This medicine contains less than 1 mmol sodium (23 mg) per prolonged-release tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.
The starting dose for adults is one 375 mg tablet twice a day. After 2−4 weeks, your doctor may increase the dose to get the right effect. The maximum dose of Ranolazine is 750 mg twice a day.
It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranolazine.
Children and adolescents under 18 years old should not take this medicine.
If you accidentally take too many Ranolazine tablets or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.
If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:
Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with this medicine.
Other side effects you may experience include the following:
Common side effects (occur in 1 to 10 users in 100) are:
Uncommon side effects (occur in 1 to 10 users in 1,000) are:
Rare side effects (occur in 1 to 10 users in 10,000) are:
Not known side effects (frequency cannot be estimated from the available data) are:
If you get any side effects, talk to your doctor or, pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme website www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on each blister strip of tablets and on the outside of the carton and bottle after EXP. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg of ranolazine.
The other ingredients are: methacrylic Acid – ethyl acrylate copolymer (1:1), microcrystalline cellulose, hypromellose, sodium hydroxide and magnesium stearate.
Depending on the tablet strength, the tablet coatings also contain:
375 mg tablet: hypromellose , titanium dioxide, macrogol, polysorbate 80 and FD&C Blue#2/Indigotine Aluminum Lake
500 mg tablet: polyvinyl alcohol, titanium dioxide, macrogol, talc, yellow iron oxide and red iron oxide
750 mg tablet: hypromellose, lactose monohydrate, titanium dioxide, triacetin, yellow iron oxide , FD&C Blue#1/FCF Fast Blue Aluminium Lake
Ranolazine prolonged-release tablets are oval shaped tablets.
The 375 mg tablets are pale blue and are engraved with 375 on one side. The size is 15 x 8 mm approximately.
The 500 mg tablets are light orange and are engraved with 500 on one side. The size is 17 x 8 mm approximately.
The 750 mg tablets are pale green and are engraved with 750 on one side. The size is 19 x 9 mm approximately.
This medicine is supplied in carton boxes containing 30, 60, or 100 tablets in blisters.
Not all pack-sizes may be marketed.
This leaflet was last revised in September 2024.